Equities

Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)356.45
  • Today's Change-0.600 / -0.17%
  • Shares traded90.31k
  • 1 Year change+11.11%
  • Beta0.6459
Data delayed at least 15 minutes, as of Jul 26 2024 11:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company is a provider of specialty healthcare focused on cancer and fertility. Under the HCG brand, the Company operates cancer care network in India in terms of the total number of private cancer treatment centers. The Company also provide fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology focused approach to diagnosis and treatment. Under the Triesta brand, it offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company also operates comprehensive cancer care center in Indore, Madhya Pradesh. The Company is also engaged in radiation business in Indore, Madhya Pradesh.

  • Revenue in INR (TTM)19.08bn
  • Net income in INR481.40m
  • Incorporated1998
  • Employees5.50k
  • Location
    Healthcare Global Enterprises LtdTower Block, Unity Building Complex,No.3, Mission RoadBANGALORE 560027IndiaIND
  • Phone+91 8 046607700
  • Fax+91 8 046607749
  • Websitehttps://hcgel.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HCG:NSI since
announced
Transaction
value
SRJ CBCC Cancer HospitalDeal completed04 Oct 202304 Oct 2023Deal completed0.13%--
Amrish Oncology Services Pvt Ltd-Radiation BusinessAnnounced10 Aug 202310 Aug 2023Announced6.37%1.93m
SRJ Health Care Pvt Ltd-Oncology businessAnnounced10 Aug 202310 Aug 2023Announced6.37%1.93m
Data delayed at least 15 minutes, as of Jul 26 2024 11:19 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Max India Ltd1.76bn-563.80m13.75bn19.00--2.79--7.83-13.08-13.0840.74114.050.24432.0330.12---7.87---9.95--66.9165.15-32.22-24.362.43-18.420.0813---12.642.82-443.01------
GPT Healthcare Ltd3.04bn377.89m14.22bn1.89k36.706.5125.504.684.724.7238.0026.630.90447.3612.371,610,983.0011.2410.1814.7312.9779.3277.9912.4310.330.932610.810.12270.0010.8518.4222.4626.15-5.19--
Krsnaa Diagnostics Ltd6.20bn568.40m22.48bn2.56k39.962.7817.113.6317.4217.42190.03250.790.59534.384.82--5.466.726.688.5977.2482.559.1711.741.374.230.1648--27.2024.25-8.49--14.21--
Indraprastha Medical Corporation Ltd12.45bn1.24bn24.87bn2.95k20.065.2015.162.0013.5213.52135.7652.121.9566.2219.66--19.3912.7425.2117.0457.4957.379.966.731.8237.750.066429.1313.299.5743.8934.2632.3422.98
Shalby Ltd9.77bn798.54m30.03bn2.68k38.83--22.183.077.217.2187.43------------4.82--5.5344.9363.928.068.20--5.78--19.1216.0115.1024.1921.578.3919.14
Artemis Medicare Services Ltd8.79bn491.41m33.86bn1.99k69.547.4637.853.853.543.5463.2933.000.93640.009.204,412,729.005.24--6.66------5.594.590.92082.950.41334.1919.149.9627.3219.12----
Yatharth Hospital & Trauma Cre Srvcs Ltd6.70bn1.14bn39.68bn--30.044.5427.605.9215.3915.3991.17101.84----------11.27--13.7380.1478.5017.0812.307.4741.510.0883--28.8845.7874.0695.813.69--
Thyrocare Technologies Ltd5.94bn776.40m41.19bn1.65k53.02--33.026.9414.6714.67112.06------------18.17--20.9770.6969.8112.8319.56--22.05--83.568.587.269.94-3.638.88-2.09
Healthcare Global Enterprises Ltd19.08bn481.40m49.67bn5.50k103.926.0123.032.603.433.43136.1259.290.759621.966.40--1.65-2.262.26-3.0553.4053.782.17-3.500.85681.390.5956--12.8014.3564.03--0.0453--
Data as of Jul 26 2024. Currency figures normalised to Healthcare Global Enterprises Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

9.75%Per cent of shares held by top holders
HolderShares% Held
Tata Asset Management Pvt Ltd.as of 30 Jun 20244.67m3.35%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Jun 20244.30m3.09%
ICICI Prudential Asset Management Co. Ltd.as of 30 Jun 20243.02m2.17%
Wellington Management International Ltd.as of 31 May 2024580.30k0.42%
Dimensional Fund Advisors LPas of 04 Jul 2024287.36k0.21%
Wellington Management Hong Kong Ltd.as of 31 Dec 2023286.59k0.21%
Fiduciary Management, Inc.as of 30 Jun 2024150.00k0.11%
BlackRock Fund Advisorsas of 04 Jul 2024117.26k0.08%
Samco Asset Management Pvt. Ltd.as of 30 Jun 202494.13k0.07%
ITI Asset Management Ltd. (India)as of 30 Jun 202479.67k0.06%
More ▼
Data from 31 Mar 2024 - 18 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.